BioCorRx Inc. (OTCMKTS:BICX) Short Interest Up 222.7% in March

BioCorRx Inc. (OTCMKTS:BICX) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 7,100 shares, an increase of 222.7% from the February 28th total of 2,200 shares. Based on an average daily volume of 10,600 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.1% of the shares of the company are short sold.

BioCorRx Stock Down 0.3 %

BICX traded down $0.00 during trading on Friday, reaching $0.35. 9,487 shares of the company were exchanged, compared to its average volume of 13,987. The company has a market cap of $5.58 million, a price-to-earnings ratio of -0.67 and a beta of 0.57. BioCorRx has a 12-month low of $0.26 and a 12-month high of $1.50. The company’s 50-day moving average is $0.39 and its two-hundred day moving average is $0.37.

About BioCorRx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.